Art

J-GLOBAL ID：202002265987781929   Reference number：20A2212143

Prognostic effect of comorbidities in patients with chronic myeloid leukemia treated with a tyrosine kinase inhibitor

チロシンキナーゼ阻害剤で治療された慢性骨髄性白血病患者における共存症の予後効果

Author (9)： Ono Takaaki (Divison of Hematology, Hamamatsu University School of Medicine, Shizuoka, Japan) ,  Takahashi Naoto (Department of Hematology, Nephrology, and Rheumatology, Akita University School of Medicine, Akita, Japan) ,  Kizaki Masahiro (Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan) ,  Kawaguchi Tatsuya (Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan) ,  Suzuki Ritsuro (Department of Oncology and Hematology, Shimane University Hospital, Izumo, Japan) ,  Yamamoto Kazuhito (Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan) ,  Ohnishi Kazunori (Tokai-Hokuriku Block Blood Center, Seto, Japan) ,  Naoe Tomoki (National Hospital Organization, Nagoya Medical Center, Nagoya, Japan) ,  Matsumura Itaru (Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka-Sayama, Japan)
Material： Cancer Science (Web)  (Cancer Sci (Web))
Volume： 111  Issue： 10  Page： 3714-3725  Publication year： 2020 
JST Material Number： U0505A  ISSN： 1349-7006  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： Charlson comorbidity index ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2212143&from=J-GLOBAL&jstjournalNo=U0505A") }}

Author keywords (5)： chronic myeloid leukemia ,  comorbidity ,  dasatinib ,  imatinib ,  nilotinib

JST classification (3)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Blood cell tumors(=neoplasms)  (GK04000M) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (3)： Imatinib ,  Dasatinib ,  Nilotinib

Terms in the title (6)： チロシンキナーゼ阻害剤 ,  治療 ,  慢性骨髄性白血病 ,  患者 ,  共存症 ,  予後